Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. 2004

Chanita Hughes Halbert, and Henry Lynch, and Jane Lynch, and David Main, and Susan Kucharski, and Anil K Rustgi, and Caryn Lerman
Abramson Cancer Center, Department of Psychiatry, and Annenberg Public Policy Center, University of Pennsylvania, 19104, USA. Chanita@mail.med.upenn.edu

BACKGROUND Although increased colonoscopic surveillance is recommended for hereditary nonpolyposis colon cancer (HNPCC) mutation carriers, limited information is available on adherence to colorectal cancer screening recommendations. This study investigated colonoscopy practices following genetic testing for HNPCC mutations. METHODS This prospective cohort study was conducted between May 22, 1996, and November 13, 1999. Participants were 98 men and women without a personal history of colon cancer or colectomy who were identified from 11 extended HNPCC families. Colonoscopy use was evaluated by telephone before genetic counseling and was reassessed 1, 6, and 12 months following test results disclosure. RESULTS During the 12 months following genetic counseling and testing, 73% (16/22) of HNPCC mutation carriers, 16% (8/49) of noncarriers, and 22% (6/27) of decliners reported having a colonoscopy (chi(2) = 23.97, P<.001). After controlling for clinical factors and pretest screening practices, HNPCC mutation carriers were significantly more likely than test decliners to have a colonoscopy (odds ratio [OR], 12.12; 95% confidence interval [CI], 3.42-42.96; P<.001). There were no differences in colonoscopy use between noncarriers and decliners (OR, 0.60; 95% CI, 0.28-1.29; P =.19). Perceived control over developing colon cancer also had a significant effect on posttest colonoscopy use (OR, 2.19; 95% CI, 1.22-3.94; P =.01). CONCLUSIONS Genetic testing may motivate increased colonoscopic screening among HNPCC mutation carriers. Increased efforts may be needed to assess patients' family histories of colon cancer and provide appropriate referrals for genetic counseling and testing to target colonoscopic screening to high-risk individuals.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D003113 Colonoscopy Endoscopic examination, therapy or surgery of the luminal surface of the colon. Colonoscopic Surgical Procedures,Surgical Procedures, Colonoscopic,Colonoscopic Surgery,Surgery, Colonoscopic,Colonoscopic Surgeries,Colonoscopic Surgical Procedure,Colonoscopies,Procedure, Colonoscopic Surgical,Procedures, Colonoscopic Surgical,Surgeries, Colonoscopic,Surgical Procedure, Colonoscopic
D003123 Colorectal Neoplasms, Hereditary Nonpolyposis A group of autosomal-dominant inherited diseases in which COLON CANCER arises in discrete adenomas. Unlike FAMILIAL POLYPOSIS COLI with hundreds of polyps, hereditary nonpolyposis colorectal neoplasms occur much later, in the fourth and fifth decades. HNPCC has been associated with germline mutations in mismatch repair (MMR) genes. It has been subdivided into Lynch syndrome I or site-specific colonic cancer, and LYNCH SYNDROME II which includes extracolonic cancer. Colon Cancer, Familial Nonpolyposis, Type 1,Colorectal Cancer, Hereditary Nonpolyposis, Type 1,Familial Nonpolyposis Colon Cancer Type 1,Hereditary Nonpolyposis Colorectal Cancer,Hereditary Nonpolyposis Colorectal Cancer Type 1,Hereditary Nonpolyposis Colorectal Neoplasms,Lynch Syndrome,Colon Cancer, Familial Nonpolyposis,Colorectal Cancer Hereditary Nonpolyposis,Familial Nonpolyposis Colon Cancer,Hereditary Nonpolyposis Colon Cancer,Lynch Cancer Family Syndrome I,Lynch Syndrome I,Syndrome, Lynch
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005820 Genetic Testing Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing. Genetic Predisposition Testing,Genetic Screening,Predictive Genetic Testing,Predictive Testing, Genetic,Testing, Genetic Predisposition,Genetic Predictive Testing,Genetic Screenings,Genetic Testing, Predictive,Predisposition Testing, Genetic,Screening, Genetic,Screenings, Genetic,Testing, Genetic,Testing, Genetic Predictive,Testing, Predictive Genetic

Related Publications

Chanita Hughes Halbert, and Henry Lynch, and Jane Lynch, and David Main, and Susan Kucharski, and Anil K Rustgi, and Caryn Lerman
July 2017, Current protocols in human genetics,
Chanita Hughes Halbert, and Henry Lynch, and Jane Lynch, and David Main, and Susan Kucharski, and Anil K Rustgi, and Caryn Lerman
April 2009, Current protocols in human genetics,
Chanita Hughes Halbert, and Henry Lynch, and Jane Lynch, and David Main, and Susan Kucharski, and Anil K Rustgi, and Caryn Lerman
January 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Chanita Hughes Halbert, and Henry Lynch, and Jane Lynch, and David Main, and Susan Kucharski, and Anil K Rustgi, and Caryn Lerman
February 1998, Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel,
Chanita Hughes Halbert, and Henry Lynch, and Jane Lynch, and David Main, and Susan Kucharski, and Anil K Rustgi, and Caryn Lerman
January 1999, Cytogenetics and cell genetics,
Chanita Hughes Halbert, and Henry Lynch, and Jane Lynch, and David Main, and Susan Kucharski, and Anil K Rustgi, and Caryn Lerman
May 1999, JAMA,
Chanita Hughes Halbert, and Henry Lynch, and Jane Lynch, and David Main, and Susan Kucharski, and Anil K Rustgi, and Caryn Lerman
June 2001, Cancer research,
Chanita Hughes Halbert, and Henry Lynch, and Jane Lynch, and David Main, and Susan Kucharski, and Anil K Rustgi, and Caryn Lerman
May 2003, The American surgeon,
Chanita Hughes Halbert, and Henry Lynch, and Jane Lynch, and David Main, and Susan Kucharski, and Anil K Rustgi, and Caryn Lerman
January 2003, Current opinion in gastroenterology,
Chanita Hughes Halbert, and Henry Lynch, and Jane Lynch, and David Main, and Susan Kucharski, and Anil K Rustgi, and Caryn Lerman
June 1994, Annals of medicine,
Copied contents to your clipboard!